Parasitic adaptive mechanisms in infection by Leishmania

Experimental and Molecular Pathology

Volumn 72, Issue 2, 2002, Pages 132-141

  Cunningham, Anna C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Adaptive mechanisms; Leishmania; Leishmaniasis; Macrophage; Parasite; Sand fly

Indexed keywords

CELL SURFACE PROTEIN; CYTOKINE; GLYCOPROTEIN GP 63; HYDROLASE; LIPOPHOSPHOGLYCAN; METALLOPROTEINASE; NITRIC OXIDE; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ADAPTATION; ARTICLE; BLOOD FLOW; CELL DEGENERATION; CELL FUNCTION; CYTOKINE PRODUCTION; ENDOCYTOSIS; FLY; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; LEISHMANIA; LEISHMANIASIS; LYSOSOME; MACROPHAGE; NONHUMAN; PARASITE MIGRATION; PARASITE SURVIVAL; PARASITE TRANSMISSION; PARASITE VECTOR; PARASITE VIRULENCE; PHAGOSOME; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

PHLEBOTOMINAE;

EID: 0036343130     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.2002.2418     Document Type: Article

References (105)

1. Leishmaniasis
2. Leishmaniasis: Public health aspects and control
3. Taxonomy of the genus Leishmania: Present and future trends and their implications
4. The leishmaniases as model zoonoses
5. Leishmania parasites and their ploys to disrupt macrophage activation
6. DNA-based methods in the detection of Leishmania parasites: Field applications and practicalities
7. Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization
8. Vaccines against leishmaniasis
9. Glycoconjugates in Leishmania infectivity
10. The interaction of Leishmania species with macrophages
11. Metacyclogenesis in Leishmania promastigotes
12. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
13. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis
14. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection
15. Leishmania species: Models of intracellular parasitism
16. Tumour necrosis factor-α synergises with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide
17. IL-4 induces a Th2 response in Leishmania major-infected mice
18. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution from macrophages to stimulate IFN-gamma production is IFN-gamma-dependent
19. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcεRII/CD23 surface antigen
20. Interleukin-10 and interleukin-4 inhibits intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation
21. Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major
22. Expression of LPG and GP63 by different development stages of Leishmania major in the sandfly, Phlebotomus papatasi
23. The fine structure and surface glycoconjugate expression of three life stages of Leishmania major
24. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage
25. Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut
26. Deficiency in β1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania-sand fly interaction
27. The agglutination of erythrocytes and Leishmania parasites by sand fly gut extracts: Evidence for lectin activity
28. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages
29. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major
30. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes
31. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9
32. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum
33. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion and resistance to complement-mediated lysis
34. Exploitation of the complement system by Leishmania promastigotes
35. Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein
36. C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages
37. The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL-10
38. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-α and induces IL-6 by mouse macrophages through interaction with the PACAP receptor
39. Immunomodulatory properties of maxadilan, a peptide derived from sand fly saliva
40. Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages
41. Comparison of receptors required for entry of Leishmania major amastigotes into macrophages
42. Purification, partial characterization and immunolocalization of a proteophosphoglycan secreted by Leishmania mexicana amastigotes
43. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes
44. Regulation of interleukin-12 by complement receptor 3 signaling
45. Selective suppression of interleukin-12 induction after macrophage receptor ligation
46. The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes
47. A heparin-binding activity on Leishmania amastigotes which mediates adhesion to cellular proteoglycans
48. In vitro parasite monocytes interactions in human leishmaniasis: Possible role of fibronectin in parasite attachment
49. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum
50. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages
51. The involvement of a major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages
52. Evidence that Leishmania donovani utilises a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism
53. Lipophosphoglycan (LPG) of Leishmania mexicana promastigotes binds to the CR3, p150/95 and LFA-1 family of leukocyte integrins
54. The major surface protein Leishmania promastigotes in a fibronectin-like molecule
55. Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts
56. Leishmania donovani macrophage binding mediated by surface glycoproteins/antigens
57. Langerhans cells transport Leishmania major from infected skin to the draining lymph node for presentation to antigen-specific T cells
58. Cutaneous leishmaniasis: A model for analysis of the immuno-regulation by accessory cells
59. The immune response to Leishmania: Mechanisms of parasite control and evasion
60. Biogenesis of phagolysosomes: The kiss and run hypothesis
61. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids
62. Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana
63. Proteophosphoglycan secreted by Leishmania mexicana amastigotes causes vacuole formation in macrophages
64. Potent inhibition of viral fusion by the lipophosphoglycan of Leishmania donovani
65. Biology of macrophages-Leishmania interactions
66. Solution structure of the lipophosphoglycan of Leishmania donovani
67. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages
68. Stimulus-response coupling in monocytes infected with Leishmania: Attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates
69. The lipophosphoglycan of Leishmania and macrophage protein kinase C
70. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection
71. Exploitation of host cell signaling machinery: Activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis
72. Attenuation of γ-interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: Selective inhibition of signaling through Janus kinases and Stat1
73. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
74. Modulation of interferon-γ-induced macrophage activation by phosphotyrosine phosphatases inhibition
75. Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C
76. Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan
77. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan
78. Down-regulation of MARCKs-related protein (MRP) in macrophages infected with Leishmania
79. Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania
80. Regulation of biosynthesis of nitric oxide
81. Altered immune responses in mice lacking inducible nitric oxide synthase
82. Invasion, control and persistence of Leishmania parasites
83. Isolation and characterization of the Leishmania donovani kineto-plastid membrane protein-11, a major immunoreactive membrane glycoprotein
84. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes
85. Microbial glycolipids: Possible virulence factors that scavenge oxygen radicals
86. Leishmania major: Inhibition of the chemiluminescent response of human polymorphonuclear leukocytes by promastigotes and their excreted factors
87. Leishmania major surface protease gp63 interferes with the function of human monocytes and neutrophils in vitro
88. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice
89. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production
90. Regulation of interleukin-12 by complement receptor 3 signaling
91. Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I
92. Modulation of macrophage function by transforming growth factor-β, interleukin 4 and interleukin 10
93. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells
94. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani
95. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-γ prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-α and interleukin 1
96. Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1β gene expression in human monocytes via a unique promoter sequence
97. Transforming growth factor-β in leishmanial infection: A parasite escape mechanism
98. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major
99. Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes
100. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan
101. Cord factor (α,α-trehalose 6,6-dimycolate) inhibits fusion between phospholipid vesicles